Medicare Enrolled

Dr. Annamarie Paulsen, MD

Child & Adolescent Psychiatry Physician · Conyers, GA
Speaking/Promotional
1397 MANCHESTER DR NE, Conyers, GA 30012
7709220255
In practice since 2007 (19 years)
NPI: 1285766055 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Paulsen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Paulsen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Paulsen

Dr. Annamarie Paulsen is a child & adolescent psychiatry physician in Conyers, GA, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Paulsen received a total of $24,323 from 39 pharmaceutical and/or device companies across 614 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in child & adolescent psychiatry physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Paulsen is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice $24,323 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$24,323
Total received (2018-2024)
Avg $3,475/year across 7 years
Top 6% in GA for child & adolescent psychiatry physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
614
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$15,040 (61.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,283 (38.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,331
2023
$1,918
2022
$1,331
2021
$1,581
2020
$255
2019
$15,699
2018
$1,209

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Neurocrine Biosciences, Inc.
$336
Tris Pharma Inc
$252
Otsuka America Pharmaceutical, Inc.
$245
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$220
Lundbeck LLC
$203
ABBVIE INC.
$178
IRONSHORE PHARMACEUTICALS INC.
$152
Axsome Therapeutics, Inc.
$149
Corium, LLC
$103
Bausch Health US, LLC
$72
Vanda Pharmaceuticals Inc.
$67
Noven Therapeutics, LLC
$61
Supernus Pharmaceuticals, Inc.
$59
Janssen Pharmaceuticals, Inc
$53
Alkermes, Inc.
$48
Almatica Pharma LLC
$47
Takeda Pharmaceuticals U.S.A., Inc.
$32
E.R. Squibb & Sons, L.L.C.
$22
IDORSIA PHARMACEUTICALS US INC
$18
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
Top 3 companies account for 35.7% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$15,721
Supernus Pharmaceuticals, Inc.
$850
Takeda Pharmaceuticals U.S.A., Inc.
$691
Lundbeck LLC
$632
ITI, Inc.
$603
Neurocrine Biosciences, Inc.
$587
ABBVIE INC.
$521
AbbVie Inc.
$471
Teva Pharmaceuticals USA, Inc.
$464
Tris Pharma Inc
$459
Allergan Inc.
$340
Janssen Pharmaceuticals, Inc
$292
Corium, LLC
$240
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$220
Indivior Inc.
$213
JAZZ PHARMACEUTICALS INC.
$194
Shire North American Group Inc
$182
Axsome Therapeutics, Inc.
$176
Alkermes, Inc.
$175
Avanir Pharmaceuticals, Inc.
$154
IRONSHORE PHARMACEUTICALS INC.
$152
Bausch Health US, LLC
$147
IDORSIA PHARMACEUTICALS US INC
$119
Noven Therapeutics, LLC
$113
ARBOR PHARMACEUTICALS, INC.
$104
Ironshore Pharmaceuticals Inc.
$74
Vanda Pharmaceuticals Inc.
$67
Neos Therapeutics, LP
$61
Almatica Pharma LLC
$47
Adlon Therapeutics L.P.
$45
Vertical Pharmaceuticals, LLC
$37
Allergan, Inc.
$33
OWP Pharmaceuticals, Inc.
$32
PFIZER INC.
$23
E.R. Squibb & Sons, L.L.C.
$22
Sunovion Pharmaceuticals Inc.
$22
Rhodes Pharmaceuticals L.P.
$17
Otsuka Pharmaceutical Development & Commercialization, Inc.
$13
Neuronetics, Inc.
$10
Top 3 companies account for 71.0% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Amitiza · Aptensio XR · Austedo XR · Auvelity · Azstarys · BRINTELLIX · CAPLYTA · COBENFY · Cotempla XR-ODT · Dyanavel XR · Evekeo · Evekeo ODT · FANAPT · Horizant · INGREZZA · INVEGA SUSTENNA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LINZESS · LOREEV XR · Lamotrigine Starter Kit · METHYLPHENIDATE 72 · MYDAYIS · NEUROSTAR TMS THERAPY SYSTEM · NUEDEXTA · Nuedexta · Onyda XR · QELBREE · QUILLICHEW ER · QUVIVIQ · Qelbree · Quillichew ER · Quillivant · Quillivant XR · REXULTI · SPRAVATO · SUBLOCADE · SUNOSI · Subvenite · TRINTELLIX · Trintellix · UZEDY · VRAYLAR · VYVANSE · Vivitrol 380 mg · Vyvanse · WELLBUTRIN XL · Xelstrym
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in child & adolescent psychiatry physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for child & adolescent psychiatry physician in GA.

Looking for a child & adolescent psychiatry physician in Conyers?
Compare child & adolescent psychiatry physicians in the Conyers area by procedure volume, costs, and industry payment transparency.
Browse child & adolescent psychiatry physicians nearby

Geographic Context

Child & adolescent psychiatry physicians within 10 mi
67
Per 100K population
71.1
County median income
$72,349
Nearest hospital
PIEDMONT ROCKDALE HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Paulsen is a child & adolescent psychiatry physician, with speaking/promotional industry engagement in the top 6% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Paulsen receive payments from pharmaceutical companies?
Yes. Dr. Paulsen received a total of $24,323 from 39 companies across 614 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Paulsen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Child & Adolescent Psychiatry Physicians in Conyers
Browse child & adolescent psychiatry physicians in Conyers ranked by procedure volume and transparency data.
Highest volume
Top Child & Adolescent Psychiatry Physicians in GA
Child & adolescent psychiatry physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Child & Adolescent Psychiatry Physicians in GA
Which GA child & adolescent psychiatry physicians receive the most from drug and device companies.
By company
Otsuka America Pharmaceutical, Inc. Payments to Doctors
See all physicians who received payments from Otsuka America Pharmaceutical, Inc.
By company
Supernus Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Supernus Pharmaceuticals, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →